203
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Hepatic Veno-occlusive disease (VOD) in multiple myeloma patient receiving Belantamab Mafodotin

, , , , , & show all
Pages 904-906 | Received 07 Sep 2022, Accepted 03 Feb 2023, Published online: 15 Feb 2023
 

Informed consent

Informed consent has been obtained from the patient.

Author contributions

The first author (I.P) was responsible for the main writing of the study, and all authors revised the paper.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.